Canada · Health Canada Drug Product Database
VAMIN N
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 18264
- DIN
- 02065665
- Form
- Solution
- Company as listed by source
- FRESENIUS KABI AB
- Source status
- Cancelled Post Market (2006-07-17)
- Source last updated
- 2025-03-22
Source-listed ingredients
- L-ISOLEUCINE — 390 MG — per 100 ML
- L-LEUCINE — 530 MG — per 100 ML
- L-LYSINE (L-LYSINE HYDROCHLORIDE) — 390 MG — per 100 ML
- METHIONINE — 190 MG — per 100 ML
- L-PHENYLALANINE — 550 MG — per 100 ML
- L-THREONINE — 300 MG — per 100 ML
- TRYPTOPHAN — 100 MG — per 100 ML
- L-VALINE — 425 MG — per 100 ML
- L-ALANINE — 300 MG — per 100 ML
- L-ARGININE — 330 MG — per 100 ML
- L-ASPARTIC ACID — 410 MG — per 100 ML
- L-CYSTEINE (L-CYSTEINE HYDROCHLORIDE) — 140 MG — per 100 ML
- GLUTAMIC ACID — 900 MG — per 100 ML
- GLYCINE — 210 MG — per 100 ML
- HISTIDINE — 240 MG — per 100 ML
- L-PROLINE — 810 MG — per 100 ML
- SERINE — 750 MG — per 100 ML
- L-TYROSINE — 50 MG — per 100 ML
- CALCIUM CHLORIDE — 36.8 MG — per 100 ML
- MAGNESIUM SULFATE — 37 MG — per 100 ML
- POTASSIUM CHLORIDE — 37.5 MG — per 100 ML
- POTASSIUM HYDROXIDE — 97 MG — per 100 ML
- SODIUM HYDROXIDE — 200 MG — per 100 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 500/1000 Ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →